Pages

Friday, December 18, 2015

GSK buys HIV medicines for $1.4bn

GlaxoSmithKline ends a frenetic week for the pharmaceutical sector with a $1.4bn takeover of HIV drug development assets from Bristol-Myers Squibb.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Comments system

Disqus Shortname